Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.96 USD | -7.76% |
|
+5.57% | +146.44% |
Business Summary
Number of employees: 296
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Dermatological Treatments
100.0
%
| 4 | 100.0 % | 60 | 100.0 % | +1,517.09% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 4 | 100.0 % | 60 | 100.0 % | +1,517.09% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Todd Watanabe
CEO | Chief Executive Officer | 56 | 15-12-31 |
Rajvir Madan
CTO | Chief Tech/Sci/R&D Officer | - | 21-05-31 |
Jay Ramsinghani
COO | Chief Operating Officer | - | 20-05-26 |
Patrick Burnett
CTO | Chief Tech/Sci/R&D Officer | 52 | 20-07-31 |
Courtney Barton
CMP | Compliance Officer | 41 | 21-02-17 |
Howard Welgus
BRD | Director/Board Member | 72 | 15-12-31 |
Ayisha Jeter
SAM | Sales & Marketing | - | 20-05-31 |
Tood Tucker
HRO | Human Resources Officer | - | 20-06-30 |
Jessica Robison
AUD | Comptroller/Controller/Auditor | - | 18-12-31 |
Bruce Binkowitz
PRN | Corporate Officer/Principal | - | 21-08-22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Heron
CHM | Chairman | 53 | 16-03-31 |
Founder | 69 | 16-05-31 | |
Keith Leonard
BRD | Director/Board Member | 62 | 21-09-01 |
Halley Gilbert
BRD | Director/Board Member | 54 | 20-04-30 |
Howard Welgus
BRD | Director/Board Member | 72 | 15-12-31 |
Terrie Curran
BRD | Director/Board Member | 55 | 20-11-01 |
Todd Watanabe
CEO | Chief Executive Officer | 56 | 15-12-31 |
Sue-Jean Lin
BRD | Director/Board Member | 65 | 21-06-08 |
Director/Board Member | 37 | 22-09-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 115,764,164 | 113,251,140 ( 97.83 %) | 0 | 97.83 % |
Company contact information
Arcutis Biotherapeutics, Inc.
3027 Townsgate Road Suite 300
91361, Westlake Village
+
http://www.arcutis.com![address Arcutis Biotherapeutics, Inc.(ARQT)](https://cdn.zonebourse.com/static/address/101779542.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+146.44% | 921M | |
+16.42% | 122B | |
+19.02% | 113B | |
+3.38% | 22.66B | |
-11.63% | 16.68B | |
-16.73% | 16.61B | |
-39.57% | 16.92B | |
+2.68% | 13.62B | |
+21.16% | 11.04B | |
+108.78% | 10.43B |
- Stock Market
- Equities
- ARQT Stock
- Company Arcutis Biotherapeutics, Inc.